10th Advanced GMP Workshop
The Indian Pharmaceutical Alliance hosted the 10th Edition of the Advanced GMP Workshop by the Indian Pharmaceutical Alliance — bringing together global regulators, industry leaders , and subject matter experts to discuss the future of pharmaceutical manufacturing and quality management.
This year’s edition explores cutting-edge themes, including advanced continuous manufacturing, AI transformation in GMP, facility design, the role of academia in quality, and the evolving global quality landscape — all aimed at advancing sustainable excellence across the pharmaceutical value chain.
Catch up now: Day 1 proceedings
Indian Pharma's Strategic Future:
A Corner Office Dialogue.
Industry leaders Nandini Piramal (Chairperson, Piramal Pharma) and Arjun Juneja (Chief Operating Officer, Mankind Pharma) dissect the decade ahead with ET's Vikas Dandekar. They discuss quality, tech, and operational shifts, providing a grounded view of leadership strategies driving the industry's competitiveness for the next 10 years.
Mission
Representing 23 leading pharma companies, IPA champions policy reform, capability building, and regulatory alignment — strengthening India’s leadership in quality-assured, innovative, and accessible healthcare, putting patients first.
Innovation
that transforms healthcare
Driving an innovation-led research ecosystem to position India as a global leader in life sciences with interdisciplinary collaboration, scientific breakthroughs, and policies that enable long-term, sustainable innovation.
Inside the Lab
Quality
that builds trust
Commitment to drive excellence in pharmaceutical quality by building capabilities, benchmarking against global standards, and promoting the sharing of best practices across the industry.
Our Quality Standards
Global Reach
that expands access
Expanding global footprint of Indian companies to enhance the affordability, availability, and accessibility of quality medicines worldwide.
Track the ImpactInsights
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India’s pharmaceutical sector has become the world’s largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
External Study 10 May 2025 • 3 min read
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
News September 14, 2025
Biotech reaches for the stars, with Indian startups in tow
Fortune India
Read More ›
News September 4, 2025
Crucial drugs to be more affordable after GST cut
The Economics Times
Read More ›
External Study July 1, 2025 • 8 min read
Frost & Sullivan : Driving an Innovative Biologics Pipeline in India
Read More ›
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India’s pharmaceutical sector has become the world’s largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
External Study 10 May 2025 • 3 min read
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
Article August 28, 2025 • 4 min read
Indian Generics Leadership to Power Pharma Innovation
Read More ›
Article August 18, 2025 • 4 min read
The Importance of Balanced Intellectual Property Systems for Patients’ Access to Medicines
Read More ›
Reports September 29, 2025
Transforming Health in India: The 2030 Innovations Agenda
View Publication ›
Spotlight
CATCH UP: Pharma Launch Excellence
Missed the event? Access the webinar recording where senior experts from IPA and McKinsey share practical insights and global case studies to ensure your next product launch is a success.
Watch Now
Perspective: America’s National Security Depends on Allied Medicine
As the White House nears a decision on its Section 232 pharmaceutical investigation, which will determine whether imports of pharmaceuticals and their components pose a threat to U.S. national security, that conclusion should already be clear as it relates to generic medicines.
Read More
GST 2.0 Shot for Public Health:
GST 2.0 marks an important beginning, but affordability alone cannot secure India's healthcare future. To ensure that today's gains translate into lasting impact, cost relief must go hand in hand with a stronger innovation ecosystem.
Read MoreSpotlight
CATCH UP: Pharma Launch Excellence
Missed the event? Access the webinar recording where senior experts from IPA and McKinsey share practical insights and global case studies to ensure your next product launch is a success.
Watch NowPharmacy of the World
#1
Global leader in generic medicines
3rd
Largest pharma industry in the world by volume
5th
Largest net exporter of medicines in the world
$60B
Annual output of the Indian pharmaceutical industry
750+
FDA registered generic manufacturing sites – Highest globally
11th
Largest pharma industry in the world by value
2x
Export orientation compared to overall manufacturing sector
$30B
Value of Indian pharmaceutical exports in FY25
In Focus
25 Years of Policy, Partnership, and Progress
The Indian Pharmaceutical Alliance (IPA) was established by leading Indian pharmaceutical companies to serve as a unified voice for the industry.
1999
IPA helps shape India’s TRIPS position at the WTO, safeguarding public health priorities.
2003
IPA leads engagement on India’s patent law amendments during the shift to a product patent regime.
2005
IPA gains global recognition in policy and regulatory forums on IP, generics, and pricing.
2010
Led by IPA, a dedicated Quality Forum was established with the purpose of establishing the Indian pharma industry as a benchmark for quality and global excellence
2015
Partners with government on Make in India, API self-reliance, and affordability strategies.
2019
Plays a central role during COVID-19 — enabling vaccine access, ensuring medicine supply, and supporting emergency policy response.
2020
Hosts the first Global Innovation Summit with 3000+ attendees, outlining key imperatives to strengthen India’s life sciences innovation ecosystem.
2021
IPA members lead global biosimilar exports, marking India's innovation-driven growth.
2024
IPA marks 25 years — championing policy, access, innovation, and global healthcare leadership.